184 related articles for article (PubMed ID: 27784330)
1. C5aR inhibition in the early inflammatory phase does not affect bone regeneration in a model of uneventful fracture healing.
Ehrnthaller C; Huber-Lang M; Kovtun A; Rapp AE; Kemmler J; Gebhard F; Ignatius A
Eur J Med Res; 2016 Oct; 21(1):42. PubMed ID: 27784330
[TBL] [Abstract][Full Text] [Related]
2. C5aR-antagonist significantly reduces the deleterious effect of a blunt chest trauma on fracture healing.
Recknagel S; Bindl R; Kurz J; Wehner T; Schoengraf P; Ehrnthaller C; Qu H; Gebhard F; Huber-Lang M; Lambris JD; Claes L; Ignatius A
J Orthop Res; 2012 Apr; 30(4):581-6. PubMed ID: 21922535
[TBL] [Abstract][Full Text] [Related]
3. Complement C5a is detrimental to histological and functional locomotor recovery after spinal cord injury in mice.
Li L; Xiong ZY; Qian ZM; Zhao TZ; Feng H; Hu S; Hu R; Ke Y; Lin J
Neurobiol Dis; 2014 Jun; 66():74-82. PubMed ID: 24607885
[TBL] [Abstract][Full Text] [Related]
4. Conversion from external fixator to intramedullary nail causes a second hit and impairs fracture healing in a severe trauma model.
Recknagel S; Bindl R; Wehner T; Göckelmann M; Wehrle E; Gebhard F; Huber-Lang M; Claes L; Ignatius A
J Orthop Res; 2013 Mar; 31(3):465-71. PubMed ID: 23070742
[TBL] [Abstract][Full Text] [Related]
5. Complement C3 and C5 deficiency affects fracture healing.
Ehrnthaller C; Huber-Lang M; Nilsson P; Bindl R; Redeker S; Recknagel S; Rapp A; Mollnes T; Amling M; Gebhard F; Ignatius A
PLoS One; 2013; 8(11):e81341. PubMed ID: 24260573
[TBL] [Abstract][Full Text] [Related]
6. The regeneration and augmentation of bone with injectable osteogenic cell sheet in a rat critical fracture healing model.
Shimizu T; Akahane M; Morita Y; Omokawa S; Nakano K; Kira T; Onishi T; Inagaki Y; Okuda A; Kawate K; Tanaka Y
Injury; 2015 Aug; 46(8):1457-64. PubMed ID: 26021664
[TBL] [Abstract][Full Text] [Related]
7. Exposure to 100% Oxygen Abolishes the Impairment of Fracture Healing after Thoracic Trauma.
Kemmler J; Bindl R; McCook O; Wagner F; Gröger M; Wagner K; Scheuerle A; Radermacher P; Ignatius A
PLoS One; 2015; 10(7):e0131194. PubMed ID: 26147725
[TBL] [Abstract][Full Text] [Related]
8. C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice.
Shagdarsuren E; Bidzhekov K; Mause SF; Simsekyilmaz S; Polakowski T; Hawlisch H; Gessner JE; Zernecke A; Weber C
Circulation; 2010 Sep; 122(10):1026-36. PubMed ID: 20733098
[TBL] [Abstract][Full Text] [Related]
9. Ovariectomy-Induced Osteopenia Influences the Middle and Late Periods of Bone Healing in a Mouse Femoral Osteotomy Model.
Pang J; Ye M; Gu X; Cao Y; Zheng Y; Guo H; Zhao Y; Zhan H; Shi Y
Rejuvenation Res; 2015 Aug; 18(4):356-65. PubMed ID: 25694054
[TBL] [Abstract][Full Text] [Related]
10. Human parathyroid hormone (1-34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys.
Manabe T; Mori S; Mashiba T; Kaji Y; Iwata K; Komatsubara S; Seki A; Sun YX; Yamamoto T
Bone; 2007 Jun; 40(6):1475-82. PubMed ID: 17369013
[TBL] [Abstract][Full Text] [Related]
11. Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model.
Atkinson SM; Nansen A; Usher PA; Sondergaard BC; Mackay CR; Friedrichsen B; Chang CC; Tang R; Skov S; Haase C; Hornum L
Autoimmunity; 2015; 48(7):460-70. PubMed ID: 25915570
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological inhibition of IL-6 trans-signaling improves compromised fracture healing after severe trauma.
Kaiser K; Prystaz K; Vikman A; Haffner-Luntzer M; Bergdolt S; Strauss G; Waetzig GH; Rose-John S; Ignatius A
Naunyn Schmiedebergs Arch Pharmacol; 2018 May; 391(5):523-536. PubMed ID: 29497762
[TBL] [Abstract][Full Text] [Related]
13. The Complement Receptor C5aR Controls Acute Inflammation and Astrogliosis following Spinal Cord Injury.
Brennan FH; Gordon R; Lao HW; Biggins PJ; Taylor SM; Franklin RJ; Woodruff TM; Ruitenberg MJ
J Neurosci; 2015 Apr; 35(16):6517-31. PubMed ID: 25904802
[TBL] [Abstract][Full Text] [Related]
14. [The roles of C5a and C5aR antagonist in TNF-α secretion and CD88 expression of BV2 microglial cells treated with Aβ1-42 oligomer].
Yang F; Li D; Xu S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Mar; 29(3):265-8. PubMed ID: 23643083
[TBL] [Abstract][Full Text] [Related]
15. Systemic administration of sclerostin monoclonal antibody accelerates fracture healing in the femoral osteotomy model of young rats.
Feng G; Chang-Qing Z; Yi-Min C; Xiao-Lin L
Int Immunopharmacol; 2015 Jan; 24(1):7-13. PubMed ID: 25479724
[TBL] [Abstract][Full Text] [Related]
16. C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist.
Bao L; Osawe I; Puri T; Lambris JD; Haas M; Quigg RJ
Eur J Immunol; 2005 Aug; 35(8):2496-506. PubMed ID: 16052609
[TBL] [Abstract][Full Text] [Related]
17. Short-term muscle atrophy caused by botulinum toxin-A local injection impairs fracture healing in the rat femur.
Hao Y; Ma Y; Wang X; Jin F; Ge S
J Orthop Res; 2012 Apr; 30(4):574-80. PubMed ID: 21919046
[TBL] [Abstract][Full Text] [Related]
18. Hydrogel-based Delivery of rhBMP-2 Improves Healing of Large Bone Defects Compared With Autograft.
Krishnan L; Priddy LB; Esancy C; Li MT; Stevens HY; Jiang X; Tran L; Rowe DW; Guldberg RE
Clin Orthop Relat Res; 2015 Sep; 473(9):2885-97. PubMed ID: 25917422
[TBL] [Abstract][Full Text] [Related]
19. Antagonist of C5aR prevents cardiac remodeling in angiotensin II-induced hypertension.
Zhang C; Li Y; Wang C; Wu Y; Du J
Am J Hypertens; 2014 Jun; 27(6):857-64. PubMed ID: 24419904
[TBL] [Abstract][Full Text] [Related]
20. Time-dependent effects of sclerostin antibody on a mouse fracture healing model.
Cui L; Cheng H; Song C; Li C; Simonet WS; Ke HZ; Li G
J Musculoskelet Neuronal Interact; 2013 Jun; 13(2):178-84. PubMed ID: 23728104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
